Suchen Sie nach Informationen zu Hauptsitz Von Vertex Pharmaceuticals Incorporated? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Vertex Pharmaceuticals - Wikipedia

    https://en.wikipedia.org/wiki/Vertex_Pharmaceuticals#:~:text=Vertex%20Pharmaceuticals%20is%20an%20American%20biopharmaceutical%20company%20based,of%20rational%20drug%20design%20rather%20than%20combinatorial%20chemistry.
    none

Vertex Pharmaceuticals | Home

    https://www.vrtx.com/
    Our investigational medicine for the potential treatment of APOL1-mediated kidney disease receives two regulatory designations. Learn more. Vertex presents new data on Phase 1/2 clinical trial for type 1 diabetes at American Diabetes Association Scientific Sessions Conference. Learn more. View our 2021 Corporate Responsibility Report. Learn more.

Vertex Pharmaceuticals - Wikipedia

    https://en.wikipedia.org/wiki/Vertex_Pharmaceuticals
    none

Vertex Pharmaceuticals Incorporated Company Profile

    https://www.dnb.com/business-directory/company-profiles.vertex_pharmaceuticals_incorporated.d1f9146a8bd86d95ffe3a27028b6f2d6.html
    Company Description: Vertex Pharmaceuticals is focused on developing treatments for cystic fibrosis (CF) and other life-threatening diseases. The biotechnology firm has four commercial drugs -- Trikafta, Orkambi, Kalydeco, and Symdeko/Symkevi -- used to treat CF. Vertex has other drugs in development including additional CF treatments and medications addressing sickle …

Vertex Pharmaceuticals - Crunchbase Company Profile

    https://www.crunchbase.com/organization/vertex-pharmaceuticals
    Contact Email [email protected]. Phone Number 617-341-6100. Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies.

Vertex Pharmaceuticals Company Profile - Craft

    https://craft.co/vertex-pharmaceuticals
    NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vertex Pharmaceuticals Incorporated (“Vertex” or the “Company”) (NASDAQ: VRTX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

SEC.gov | Vertex Pharmaceuticals, Inc.

    https://www.sec.gov/vertex-pharmaceuticals-inc
    Vertex Pharmaceuticals, Inc. June 19, 2018 Downloads. pdf 18-02346-T.pdf (448.52 KB) Modified: June 19, 2018 STAY CONNECTED 1 Twitter 2 Facebook 3 RSS 4 YouTube 6 LinkedIn 8 Email Updates. About The SEC. Budget & Performance; Careers; Commission Votes; Contact; Contracts; Data Resources ...

Vertex Pharmaceuticals Inc - Company Profile and News

    https://www.bloomberg.com/profile/company/VRTX*:MM
    Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of …

Vertex Pharmaceuticals Inc - Company Profile and News

    https://www.bloomberg.com/profile/company/VRTX:US
    Company profile page for Vertex Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information

VRTX | Vertex Pharmaceuticals Inc. Company Profile

    https://www.wsj.com/market-data/quotes/VRTX/company-people
    Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small …

VRTX | Vertex Pharmaceuticals Inc. Profile | MarketWatch

    https://www.marketwatch.com/investing/stock/vrtx/company-profile
    Vertex Pharmaceuticals Inc. 50 Northern Avenue. Boston, Massachusetts 02210. Phone 1 617 341-6100. Industry Pharmaceuticals. Sector Health Care/Life Sciences.

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Vertex Pharmaceuticals Incorporated gefunden haben.